Natural killer-enhancing factor (NKEF) was identified and cloned on th
e basis of its ability to increase NK cytotoxicity. Two genes, NKEF-A
and -B, encode NKEF proteins and sequence analysis presented suggests
that each belongs to a highly conserved family of antioxidants. To exa
mine the antioxidant potential of NKEF, we transfected the coding regi
on of NKEF-B cDNA into the human endothelial cell line ECV304. The sta
ble transfectant, B/1, was found to overexpress NKEF-B gene transcript
and protein. We subjected B/1 to oxidative stress by either culturing
them with glucose oxidase (GO), which continuously generates hydrogen
peroxide, or by direct addition of hydrogen peroxide. We found that B
/1 cells were more resistant than control cell lines. Resistance to hy
drogen peroxide was originally thought to be mediated mainly by catala
se and the glutathione cycle. Therefore,we used inhibitors to block th
e two pathways and found that B/1 cells were more resistant to oxidati
ve stress than control cells when we used inhibitors to preblock eithe
r pathway. We also examined the cellular inflammatory responses to oxi
dized low-density lipoprotein (LDL) and bacterial lipopolysaccharide (
LPS) by measuring monocyte adhesion to endothelial cells in vitro and
found that B/1 cells were resistant to such responses. Lastly, we foun
d that B/1 cells were more resistant to a novel chemotherapeutic agent
CT-2584, which appears to kill tumor cells by stimulating production
of reactive oxygen intermediates in mitochondria. These results demons
trate that the NKEF-B is an antioxidant that protects cells from oxida
tive stress, chemotherapy agents, and inflammation-induced monocyte ad
hesion. Furthermore, its expression may mediate cellular responses to
proinflammatory molecules. Copyright (C) 1996 Elsevier Science Inc.